Financials
- Market Capitalization 3.83 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.93
ratio cours/chiffre d'affaires
30.46
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1523 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.48 USD | +1.98% | -4.91% | +69.94% | +246.53% | 3.84 B USD | ||
| 1525 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 8.46 USD | +2.17% | -0.12% | +106.34% | +288.07% | 3.83 B USD | ||
| 1555 | DNLI Denali Therapeutics Inc. - Common Stock | 23.16 USD | -0.47% | -5.74% | +1.36% | +43.23% | 3.70 B USD | ||
| 1560 | TNGX Tango Therapeutics, Inc. - Common Stock | 21.80 USD | -2.46% | -13.97% | -18.75% | +229.31% | 3.68 B USD |